tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Noxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN™
PremiumCompany AnnouncementsNoxopharm Advances HERACLES Trial for Autoimmune Drug SOF-SKN™
2M ago
Noxopharm Advances Clinical Trials and Expands Collaborations
Premium
Company Announcements
Noxopharm Advances Clinical Trials and Expands Collaborations
2M ago
Noxopharm Initiates First SOF-SKN™ Dose in HERACLES Trial
Premium
Company Announcements
Noxopharm Initiates First SOF-SKN™ Dose in HERACLES Trial
3M ago
Noxopharm Sells Entire Stake in Nyrada Inc., Restructuring Corporate Holdings
PremiumCompany AnnouncementsNoxopharm Sells Entire Stake in Nyrada Inc., Restructuring Corporate Holdings
4M ago
Noxopharm Secures $2.5 Million for Clinical Trials and R&D
Premium
Company Announcements
Noxopharm Secures $2.5 Million for Clinical Trials and R&D
4M ago
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
Premium
Company Announcements
Noxopharm Unveils Promising SOF-SKN Data at Rheumatology Conference
5M ago
Noxopharm Partners with Doherty Clinical Trials for HERACLES Trial
PremiumCompany AnnouncementsNoxopharm Partners with Doherty Clinical Trials for HERACLES Trial
7M ago
Noxopharm Reports Half-Year Financial Results and Strategic Focus
Premium
Company Announcements
Noxopharm Reports Half-Year Financial Results and Strategic Focus
7M ago
Noxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
Premium
Company Announcements
Noxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100